Tech Moves: Eliem CEO out amid layoffs; Rokt taps Amazon vet to lead new Seattle office; and more — Bob Azelby is leaving his position as president and CEO of Elieum Therapeutics and stepping down from its board.… Read More
Eliem Therapeutics shares sink more than 50% after lead program fails to show benefit in clinic Shares of Eliem Therapeutics fell more than 50% Monday after the company reported disappointing clinical data. Its compound to treat… Read More
Eliem Therapeutics files for IPO as another Seattle-area biotech firm set to go public Eliem Therapeutics, a clinical stage biotech company generating therapies for pain, depression and other nervous-system related conditions, has filed to… Read More
Alder BioPharmaceuticals raises $170M in stock offering as FDA reviews its migraine therapy Alder BioPharmaceuticals has raised $170 million in a stock offering and is ramping up operations after filing an FDA application… Read More
Tech Moves: Microsoft vets move to Amazon; NurseGrid expands executive team; and more In one of two recent Microsoft-to-Amazon moves, Brian Schultz, who has worked on-and-off at Microsoft since 1999, is now working on… Read More
